Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment.

Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...

Insurers also ask the Trump administration, which is engaged in a sweeping campaign to eradicate anything related to ...

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

Novo Nordisk boasts 45 million customers using its drug, which has caused a revolution in weight-loss treatment. But competitors are nipping at its heels.

Not all growth stocks worth buying these days focus on the artificial intelligence field. There are many exciting ones in other industries -- even in healthcare, a sector some investors might consider ...

Research indicates that some individuals can achieve normal blood glucose levels on a keto diet, allowing them to reduce or ...

Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.